LOTUSEYE

LOTUS EYE HOSPITAL AND INSTITUTE

Small Cap BSE: 532998 NSE: LOTUSEYE
₹81.5
-3.45 (-4.06%)
As on 10 December, 2022 | 08:42

Lotus Eye Hospital And Institute Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in LOTUS EYE HOSPITAL AND INSTITUTE

Start SIP

Lotus Eye Hospital And Institute Share Price

Lotus Eye Hospital And Institute Share Returns

  • Over 1 Month 16.26%
  • Over 3 Month 14.95%
  • Over 6 Month 49.82%
  • Over 1 Year 63.98%

Lotus Eye Hospital And Institute Key Statistics

P/E Ratio 40.4
PEG Ratio 1.3
Market Cap Cr 170
Price to Book Ratio 3.1
EPS 1.4
Dividend 0.6
Relative Strength Index 49.43
Money Flow Index 89.24
MACD Signal 4.1
Average True Range 6.14

Lotus Eye Hospital And Institute Investment Rating

  • Master Rating:
  • Lotus Eye Hospital And Institute has an operating revenue of Rs. 45.92 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 11% is healthy, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 35% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lotus Eye Hospital and Institute Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1212111211611
Operating Expenses Qtr Cr 101099969
Operating Profit Qtr Cr 2212202
Depreciation Qtr Cr 1111111
Interest Qtr Cr 0000000
Tax Qtr Cr 0001000
Net Profit Qtr Cr 1111101

Lotus Eye Hospital And Institute Technicals

EMA & SMA

Current Price
81.5
-3.45 (-4.06%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 83.56
  • 50 Day
  • 77.8
  • 100 Day
  • 72.15
  • 200 Day
  • 65.41
  • 20 Day
  • 83.74
  • 50 Day
  • 76.54
  • 100 Day
  • 71.81
  • 200 Day
  • 63.03

Lotus Eye Hospital And Institute Resistance and Support

PIVOT
₹85.35
Resistance
First Resistance 87.6
Second Resistance 90.25
Third Resistance 92.5
RSI 49.43
MFI 89.24
MACD Single Line 4.1
MACD 3.41
Support
First Resistance 82.7
Second Resistance 80.45
Third Resistance 77.8

Lotus Eye Hospital And Institute Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 15,555 1,555,500 100
Week 29,114 2,546,619 87.47
1 Month 132,029 6,720,276 50.9
6 Month 75,312 4,127,842 54.81

Lotus Eye Hospital And Institute Result Highlights

Lotus Eye Hospital and Institute Synopsis

NSE-Medical-Hospitals

Lotus Eye Hospital belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 38.91 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2022. Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783.
Market Cap 169
Sales 46
Shares in Float 0.87
No of funds
Yield 0.61
Book Value 3.1
U/D Vol ratio 1.3
LTDebt / Equity
Alpha 0.24
Beta 1.1

Lotus Eye Hospital and Institute

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 57.88%57.74%57.74%
Individual Investors 23.13%27.13%26.95%
Others 18.99%15.13%15.31%

Lotus Eye Hospital and Institute Management

Name Designation
Dr. Kavetha Sundaramoorthy Chairman
Ms. Sangeetha Sundaramoorthy Managing Director
Dr. K S Ramalingam Executive Director & CEO
Mr. D R Kaarthikeyan Director
Dr. Yogesh Shah Director
CA. R Subramanian Director
CA. M Alagiriswamy Director
Dr. S Natesan Director

Lotus Eye Hospital And Institute Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lotus Eye Hospital And Institute Corporate Action

Date Purpose Remarks
2022-11-14 Audited Results
2022-08-09 Quarterly Results
2022-05-25 Audited Results & Final Dividend
2022-02-14 Quarterly Results
2021-11-13 Quarterly Results
Date Purpose Remarks
2022-09-10 FINAL Rs.0.50 per share(5%)Final Dividend

Lotus Eye Hospital and Institute FAQs

What is Share Price of Lotus Eye Hospital and Institute ?

Lotus Eye Hospital and Institute share price is ₹81 As on 10 December, 2022 | 08:28

What is the Market Cap of Lotus Eye Hospital and Institute ?

The Market Cap of Lotus Eye Hospital and Institute is ₹169.5 Cr As on 10 December, 2022 | 08:28

What is the P/E ratio of Lotus Eye Hospital and Institute ?

The P/E ratio of Lotus Eye Hospital and Institute is 40.4 As on 10 December, 2022 | 08:28

What is the PB ratio of Lotus Eye Hospital and Institute ?

The PB ratio of Lotus Eye Hospital and Institute is 3.1 As on 10 December, 2022 | 08:28

Q2FY23